Product Information
REFRESH OPTIVE GEL EYE DROPS is a brand product labeled by Allergan, Inc., priced at $1.0990 per ML under NDC 00023545910. Its NADAC has been published 420 times since May 18, 2016.
Strength
10; 9 mg/mL; mg/mL
Manufacturer
Allergan, Inc.NDC
00023545910
Classification
Brand
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
8/19/2026
Active Ingredients
CARBOXYMETHYLCELLULOSE SODIUM; GLYCERINApproval Type
OTC MONOGRAPH DRUG
FDA Application
M018On Market Since
9/30/2015
Pharmacological Classes
Price Statistics
The NADAC for REFRESH OPTIVE GEL EYE DROPS has been published 420 times since May 18, 2016, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.0990 per ML |
|---|---|
| All-time high | $1.1563 (Aug 12, 2026) |
| All-time low | $0.9721 (Dec 21, 2016) |
| 52-week high | $1.1563 |
| 52-week low | $1.0780 |
| Median price | $1.0342 |
| Average price | $1.0413 |
| Largest weekly change | +10.8% (Jul 19, 2017) |
| Weeks tracked | 420 |
| Tracking since | May 18, 2016 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the carboxymethylcellulose sodium and glycerin market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Allergan, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
carboxymethylcellulose sodium and glycerin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Non-Standardized Chemical Allergen class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of REFRESH OPTIVE GEL EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for REFRESH OPTIVE GEL EYE DROPS, manufactured by Allergan, Inc., is $1.0990 per ML (NDC 00023545910), effective Sep 30, 2026.
How has the price of REFRESH OPTIVE GEL EYE DROPS changed over time?
Over the history we have for it, the NADAC for REFRESH OPTIVE GEL EYE DROPS has held within roughly two percent of its current level. It has been tracked across 420 weekly CMS publications since May 18, 2016.
What are the highest and lowest recorded NADAC prices for REFRESH OPTIVE GEL EYE DROPS?
Since May 18, 2016, the NADAC for REFRESH OPTIVE GEL EYE DROPS has ranged from a low of $0.9721 (Dec 21, 2016) to a high of $1.1563 (Aug 12, 2026), with a median of $1.0342 per ML.
Are there cheaper alternatives to REFRESH OPTIVE GEL EYE DROPS?
No other NADAC-published product currently shares the active ingredient and strength of REFRESH OPTIVE GEL EYE DROPS in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures REFRESH OPTIVE GEL EYE DROPS?
REFRESH OPTIVE GEL EYE DROPS (NDC 00023545910) is labeled by Allergan, Inc., and CMS classifies it as a brand product.